Combined Implementation of Dural Puncture Epidural and Programmed Intermittent Epidural Bolus for Labor Analgesia
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03366935 |
|
Recruitment Status :
Completed
First Posted : December 8, 2017
Last Update Posted : August 1, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Labor Pain Labor Analgesia | Other: EPL and CEI Other: DPE and CEI Other: DPE and PIEB | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 120 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Participant, Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Combined Implementation of Dural Puncture Epidural Technique and Programmed Intermittent Epidural Bolus for Labor Analgesia |
| Actual Study Start Date : | October 10, 2017 |
| Actual Primary Completion Date : | June 8, 2018 |
| Actual Study Completion Date : | June 30, 2018 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: EPL and CEI
Those with receive a standard epidural (EPL) and continuous epidural infusion(CEI) + patient-controlled epidural analgesia (PCEA)
|
Other: EPL and CEI
Procedure: Standard epidural placement(EPL) Drug: ropivacaine Drug: sufentani 0.1% ropivacaine + sufentanil 0.3μg/mL Device: Infusion pump Infusion pump set to continuous epidural infusion(CEI) plus patient-controlled epidural analgesia (PCEA). |
|
Active Comparator: DPE and CEI
Those with receive a dural puncture labor epidural (DPE) and continuous epidural infusion(CEI) + patient-controlled epidural analgesia (PCEA)
|
Other: DPE and CEI
Procedure: Dural puncture epidural (DPE) Epidural with spinal needle placed to create a single dural puncture and confirm free flow of cerebral spinal fluid (CSF) , without direct medication administration into the subarachnoid space. Drug: ropivacaine Drug: sufentani 0.1% ropivacaine + sufentanil 0.3μg/mL Device: Infusion pump Infusion pump set to continuous epidural infusion(CEI) plus patient-controlled epidural analgesia (PCEA). |
|
Active Comparator: DPE and PIEB
Those with receive a dural puncture labor epidural (DPE) and programmed intermittent epidural boluses(PIEB) + patient-controlled epidural analgesia (PCEA)
|
Other: DPE and PIEB
Procedure: Dural puncture epidural (DPE) Epidural with spinal needle placed to create a single dural puncture and confirm free flow of cerebral spinal fluid (CSF) , without direct medication administration into the subarachnoid space. Drug: ropivacaine Drug: sufentani 0.1% ropivacaine + sufentanil 0.3μg/mL Device: Infusion pump Infusion pump set to programmed intermittent epidural boluses (PIEB) plus patient-controlled epidural analgesia (PCEA). |
- Compare time of onset of labor analgesia among the study groups [ Time Frame: From epidural infusion initiate to delivery ]Visual Numerical Rating Scale (VNRS) ≤ 10 mm on a 100-mm scale
- Incidence of side effect [ Time Frame: 24 hours post delivery ]maternal hypotension,fetal bradycardia, maternal motor block,post-dural puncture headache,nausea, vomiting,pruritus,nerve damage
- Sensory block level [ Time Frame: 24 hours post delivery ]Sensory block will be assessed bilaterally
- Total anesthetic dose required [ Time Frame: From epidural infusion initiate to 1h post delivery ]Including physician interventions, programmed doses, and patient controlled doses
- Mode of delivery [ Time Frame: From epidural infusion initiate to delivery ]Spontaneous, Instrumental, or cesarean delivery
- Apgar scores [ Time Frame: 30 mins post delivery ]The Apgar scale is determined by evaluating the newborn baby on five simple criteria on a scale from zero to two, then summing up the five values thus obtained. The resulting Apgar score ranges from zero to 10. The five criteria are skin color, pulse rate, reflex irritability grimace, activity and respiratoty effort
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 20 Years to 40 Years (Adult) |
| Sexes Eligible for Study: | Female |
| Gender Based Eligibility: | Yes |
| Gender Eligibility Description: | Pregnant patients |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- women requeste labor analgesia
- ASA I or II
- at 37-42 weeks' gestation
- nulliparous
- singleton pregnancy, vertex presentation
- visual Numerical Rating Scale (VNRS) at requesting analgesia > 5 (NRPS 0-10)
- cervical dilatation < 5 cm
Exclusion Criteria:
- patient refusal to participate in the study
- age <20 years or >40 years
- body mass Index(BMI)>50 (Kg/m2)
- clinically significant diseases of pregnancy (i.e.,gestational hypertension, preeclampsia, gestational placenta previa, placental abruption diabetes)
- contraindications to neuraxial analgesia
- drug abuse
- conditions associated with an increased risk of a cesarean delivery (i.e., history of uterine anomaly or surgery, morbid obesity) and known anomalies
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03366935
| China | |
| Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine | |
| Shanghai, China | |
| Study Chair: | YuJie Song, MD | Department of Anesthesiaology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Shanghai First Maternity and Infant Hospital |
| ClinicalTrials.gov Identifier: | NCT03366935 |
| Other Study ID Numbers: |
anesthesia dapartment |
| First Posted: | December 8, 2017 Key Record Dates |
| Last Update Posted: | August 1, 2018 |
| Last Verified: | July 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
labor analgesia dural puncture epidural (DPE) standard Epidural (EPL) continuous epidural infusion (CEI) programmed intermittent epidural bolus (PIEB) |
|
Labor Pain Neurologic Manifestations Pain |

